Management of rash to erlotinib (E) and cetuximab (C): Results from the SERIES (Skin and Eye Reactions to Inhibitors of EGFR and kinaseS) clinic algorithm
Year: 2007
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: N. V. Martin, V. Pacifico, S. E. Lai, A. Rademaker, S. Ortiz, M. Aneja, D. P. West, C. Bennett, M. Lacouture
Institution: Northwestern University
Language: English
Subfield: Dermatology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2278907595
